Document is current
Any future updates will be listed below
-
Authors
Kaye, Joel
Mondal, Arindam
Foty, Ramsey
Jia, Dongxuan
Langenfeld, John https://orcid.org/0000-0002-1766-3367
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA225830)
National Institutes of Health (R01CA225830S1)
Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey (U01HL150852)
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 31 January 2022
First Online: 22 February 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The use of BMP inhibitors and cell lines has been approved by Rutgers University Institutional Biosafety Committee #13-424.
